Citrobacter koseri Cellulitis During Anti-CD20 Monoclonal Antibody (Ofatumumab) Treatment for B-cell Chronic Lymphocytic Leukaemia

被引：6
|
作者：
Kluger, Nicolas [1 ]
Cartron, Guillaume [2 ]
Bessis, Didier [1 ]
Guillot, Bernard [1 ]
Girard, Celine [1 ]
机构：
[1] Univ Montpellier 1, CHU Montpellier, Hop St Eloi, Dept Dermatol, FR-34295 Montpellier, France
[2] Univ Montpellier 1, CHU Montpellier, Hop Lapeyronie, Dept Haematol, FR-34295 Montpellier, France
来源：
ACTA DERMATO-VENEREOLOGICA | 2010年 / 90卷 / 01期
关键词：
GRAM-NEGATIVE FOLLICULITIS; DIVERSUS;
D O I：
10.2340/00015555-0762
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：99 / 100
页数：2
相关论文
共 50 条
  • [21] Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies
    Gadi Gazit Bornstein
    Christophe Quéva
    Mohammad Tabrizi
    Anne van Abbema
    Carlos Chavez
    Ping Wang
    Orit Foord
    Kiran Ahluwalia
    Naomi Laing
    Sandhya Raja
    Shenghua Wen
    Larry L. Green
    Xiaodong Yang
    Carl Webster
    Ross Stewart
    David Blakey
    Investigational New Drugs, 2010, 28 : 561 - 574
  • [22] Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study
    Coiffier, Bertrand
    Lepretre, Stephane
    Pedersen, Lars Moller
    Gadeberg, Ole
    Fredriksen, Henrik
    van Oers, Marinus H. J.
    Wooldridge, James
    Kloczko, Janusz
    Holowiecki, Jerzy
    Hellmann, Anrzej
    Walewski, Jan
    Flensburg, Mimi
    Petersen, Jorgen
    Robak, Tadeusz
    BLOOD, 2008, 111 (03) : 1094 - 1100
  • [23] Development of a new fully human anti-CD20 monoclonal antibody for the treatment of B-cell malignancies
    Bornstein, Gadi Gazit
    Queva, Christophe
    Tabrizi, Mohammad
    van Abbema, Anne
    Chavez, Carlos
    Wang, Ping
    Foord, Orit
    Ahluwalia, Kiran
    Laing, Naomi
    Raja, Sandhya
    Wen, Shenghua
    Green, Larry L.
    Yang, Xiaodong
    Webster, Carl
    Stewart, Ross
    Blakey, David
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (05) : 561 - 574
  • [24] Radiolabeled anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoma
    Dillman, RO
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (16) : 3545 - 3557
  • [25] Ofatumumab - Human anti-CD20 monoclonal antibody treatment of lymphoma/leukemia treatment of rheumatoid arthritis
    Wang, Y.
    Mealy, N.
    Bays, M.
    DRUGS OF THE FUTURE, 2007, 32 (05) : 408 - 410
  • [26] Anti-CD20 Antibody Therapy for B-Cell Lymphomas
    Maloney, David G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09): : 878 - 878
  • [27] Anti-CD20 Antibody Therapy for B-Cell Lymphomas
    Maloney, David G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (21): : 2008 - 2016
  • [28] Loss of CD20 expression following treatment with anti-CD20 monoclonal antibody in chronic lymphocytic leukemia.
    Savage, KJ
    Weng, AP
    Kutok, JL
    Pinkus, G
    Gribben, JG
    BLOOD, 2002, 100 (11) : 364B - 364B
  • [29] Treatment of radiation-relapsing primary cutaneous B-cell lymphoma with an anti-CD20 monoclonal antibody
    Lacouture, ME
    Baron, JM
    Jani, AB
    Laumann, AE
    Soltani, K
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2005, 30 (01) : 46 - 48
  • [30] Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia
    Jain, Preetesh
    O'Brien, Susan
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (02) : 169 - 182
12345